 
| Received: |
by LISTSERV.REDIRIS.ES (LISTSERV-TCP/IP release 16.0) with spool id
12393476 for [log in para visualizar]; Thu, 16 Jul 2020 19:37:01
+0200
from lsv.rediris.es (lsv.rediris.es [130.206.1.61]) by
listserv.rediris.es (Postfix) with ESMTP id 9888F232FF; Thu, 16 Jul
2020 19:37:01 +0200 (CEST) |
| Content-Type: |
text/plain; charset="utf-8" |
| Date: |
Thu, 16 Jul 2020 19:37:01 +0200 |
| Reply-To: |
|
| Subject: |
|
| Message-ID: |
|
| Content-Transfer-Encoding: |
quoted-printable |
| Emisor: |
|
| Sender: |
|
| Mime-Version: |
1.0 |
| Delivered-To: |
|
| Parts/Attachments: |
|
|
Maximising the Value of Clinical Trial Data: [Advanced] Analysis for Economic Evaluation and Modelling is a natural follow-on from advanced modelling courses and covers the fundamental concepts and practice of the key advanced analytic techniques that are required when determining appropriate approaches and estimating parameter values for cost-effectiveness models. It is also highly relevant to those seeking to improve the relevance of trial based cost-effectiveness. It will be run over eight sessions over a three-week period, using a blend of live lectures from world-class experts and tutor-supported practical exercises.
The course will cover:
- Regression analysis to estimate costs and utilities based on trial data, including the use of appropriate techniques for analysing panel data with repeated measures per patient, dealing with differential follow-up, censoring, missing data and skewed data
- Survival analysis techniques including the use parametric survival analysis, competing risks analysis, cure models, and multi-state modelling
- Treatment switching techniques such as rank-preserving structural failure time (RPSFMT), inverse probability of censoring weights (IPCW) and two stage estimation models.
Dates:
Week 1: 21st - 23rd October 2020
Week 2: 28th - 30th October 2020
Week 3: 4th & 5th November 2020
To book or enquire, please email [log in para visualizar] or visit our website: https://bit.ly/3du7SUl
|
|
|
